GC Biopharma Market Cap

GC Biopharma has a market cap or net worth of 1.37 trillion as of April 17, 2025. Its market cap has decreased by -3.63% in one year.

Market Cap

1.37T

Enterprise Value

2.40T

Revenue

1.68T

Ranking

n/a

PE Ratio

n/a

Stock Price

119,600.00

Market Cap Chart

Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.37T, an increase of 4,593.07%. That is a compound annual growth rate of 13.86%.

Market Cap History

Date	Market Cap	% Change
Apr 17, 2025	1,362.73B	-33.48%
Dec 30, 2024	2,048.67B	43.03%
Dec 28, 2023	1,432.35B	-3.09%
Dec 29, 2022	1,478.01B	-40.60%
Dec 30, 2021	2,488.07B	-46.31%
Dec 30, 2020	4,633.75B	206.42%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	73.59T
Celltrion	34.41T
ALTEOGEN	20.25T
Yuhan	8,492.40B
SK Biopharmaceuticals	8,089.76B
HLB Co., Ltd.	7,094.07B
LigaChem Biosciences	3,972.88B
PharmaResearch	3,807.81B

Market Cap Rankings